Evidence map›Paper›PMID 26501788›Full record

Trial reportJournal of addiction medicine

Effects of Prereactivation Propranolol on Cocaine Craving Elicited by Imagery Script/Cue Sets in Opioid-dependent Polydrug Users: A Randomized Study.

Michelle L Jobes, Efrat Aharonovich, David H Epstein, Karran A Phillips, David Reamer, Micheline Anderson, Kenzie L Preston

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of addiction medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Does human language limit translatability of clinical and preclinical addiction research?Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2018
    Article
  15. Exacerbated Craving in the Presence of Stress and Drug Cues in Drug-Dependent Patients.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2018
    Observational
  16. Article
  17. Garcinol Blocks the Reconsolidation of Multiple Cocaine-Paired Cues after a Single Cocaine-Reactivation Session.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2017
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Michelle L JobesClinical Pharmacology and Therapeutics Research Branch, Intramural Research Program of the National Institute on Drug Abuse, Baltimore, MD (M.L.J., K.A.P., D.R., M.A., K.L.P.); and Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY (E.A.).
Efrat Aharonovich
David H Epstein
Karran A Phillips
David Reamer
Micheline Anderson
Kenzie L Preston
National Institute on Drug Abuse · US

Funding

Prevention of Relapse in AddictionZIADA000536 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI PRESTON, KENZIE · 2009 to 2018
$9.5M
Evaluation Of Treatments Of Opioid And Cocaine DependenceZIADA000175 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI PRESTON, KENZIE · 2009 to 2016
$7.4M
Modified Behavioral Treatment for Cocaine Patients with Cognitive DeficitsR01DA020647 · NIDA · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI AHARONOVICH, EFRAT · 2007 to 2010
$1.8M
Cognition in Cocaine Dependence: Assessment &TherapyK23DA016743 · NIDA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI AHARONOVICH, EFRAT · 2003 to 2007
$802k
Intramural NIH HHS Z99 DA999999NIDA NIH HHS DA-020647NIDA NIH HHS K23 DA016743NIDA NIH HHS R01 DA020647
6 · The paper itself

Abstract

objectivesRelapse to drug misuse may follow exposure to drug cues that elicit craving. The learned associations, or "emotional memories," that underlie responses to cues may be attenuated or erased by the β-adrenergic antagonist propranolol during a "reconsolidation window" shortly after the memories are reactivated by cues.

methodsWe evaluated the effects of propranolol on cue-induced drug cravings in healthy opioid-dependent individuals who used cocaine while receiving methadone maintenance (n = 33). Participants were asked to recall specific cocaine use and neutral events in an interview; these events were used to develop personalized auditory script/cue sets. Approximately 1 week later, propranolol (40 mg) or placebo (random assignment, double blind) was administered orally before presentation of the script/cue sets; the presentation of the script/cue sets were tested 1 week and 5 weeks after the propranolol/placebo session. Ongoing drug use was monitored via urine screens and self-report in twice-weekly visits.

resultsCue reactivity, as assessed by craving scales and physiological responses, was unexpectedly greater in the propranolol group than in the placebo group. This counterhypothesized group difference was present acutely during propranolol administration and seemed to persist (without reaching statistical significance) during the subsequent test sessions.

conclusionsOur results do not support the use of propranolol for cue-induced cocaine craving in opioid-maintained patients.

Indexed as

CuesAdolescentAdrenergic beta-AntagonistsAdultAnalgesics, OpioidCocaine-Related DisordersCravingDouble-Blind MethodEmotionsFemaleHumansMaleMental RecallMethadoneMiddle AgedOpiate Substitution TreatmentAdrenergic beta-AntagonistsAnalgesics, OpioidMethadonePropranolol

Identifiers

PMID26501788
PMCPMC4630075
OpenAlexW2312309180

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.